Patents by Inventor Gene Bowman

Gene Bowman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS
    Publication number: 20240041915
    Abstract: A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
    Type: Application
    Filed: October 10, 2023
    Publication date: February 8, 2024
    Inventors: Gene Bowman, Julie Laure Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat
  • METHODS FOR IDENTIFYING PRE-DISPOSITION TO COGNITIVE DECLINE AND AGENTS FOR REDUCING OR PREVENTING COGNITIVE DECLINE, OR IMPROVING COGNITIVE ABILITY
    Publication number: 20230226097
    Abstract: A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
    Type: Application
    Filed: March 10, 2023
    Publication date: July 20, 2023
    Inventors: Gene Bowman, Julie Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat, Claus Rieker
  • METHODS FOR IDENTIFYING PRE-DISPOSITION TO COGNITIVE DECLINE AND AGENTS FOR REDUCING OR PREVENTING COGNITIVE DECLINE, OR IMPROVING COGNITIVE ABILITY
    Publication number: 20210263048
    Abstract: A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin D or a metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
    Type: Application
    Filed: April 5, 2018
    Publication date: August 26, 2021
    Inventors: Gene Bowman, Julie Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat, Claus Rieker
  • OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS
    Publication number: 20210128587
    Abstract: A method for identifying pre-disposition to cognitive decline in a subject, the method comprising determining levels of: (a) omega-3 fatty acids, and vitamin Dora metabolite thereof; (b) omega-3 fatty acids, and homocysteine; (c) vitamin D or a metabolite thereof, and homocysteine; or (d) omega-3 fatty acids, vitamin D or a metabolite thereof, and homocysteine, independently in one or more samples obtained from the subject.
    Type: Application
    Filed: December 11, 2017
    Publication date: May 6, 2021
    Inventors: Gene Bowman, Julie Laure Hudry-Labbe, Jeroen Antonius Johannes Schmitt, Corina Boschat
  • BIOMARKERS OF BLOOD-BRAIN BARRIER DYSFUNCTION
    Publication number: 20190346459
    Abstract: A method for determining whether a subject has an impaired blood-brain barrier (BBB) or is at risk of developing an impaired blood-brain barrier (BBB) comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers comprise serum amyloid A (SAA).
    Type: Application
    Filed: June 22, 2017
    Publication date: November 14, 2019
    Inventors: Gene Bowman, Loic Dayon, Eugenia Migliavacca, Julius Popp